HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Grazioli Selected Research

Focal Nodular Hyperplasia

4/2018Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI.
2/2012Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
7/2008Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
7/2005Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
5/2003MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Grazioli Research Topics

Disease

9Neoplasms (Cancer)
05/2020 - 03/2003
8Hepatocellular Carcinoma (Hepatoma)
01/2020 - 07/2002
5Neoplasm Metastasis (Metastasis)
10/2019 - 07/2008
5Focal Nodular Hyperplasia
04/2018 - 05/2003
4Body Weight (Weight, Body)
02/2010 - 07/2005
2Cholangiocarcinoma
08/2020 - 12/2010
2Adrenocortical Carcinoma
05/2020 - 11/2019
2Fibrosis (Cirrhosis)
07/2013 - 09/2012
2Liver Cell Adenoma (Hepatocellular Adenoma)
01/2013 - 02/2012
2Adenoma (Adenomas)
12/2010 - 07/2005
2Pathologic Constriction (Stenosis)
04/2008 - 10/2007
1Placenta Accreta
03/2022
1Placenta Previa
03/2022
1Primary Myelofibrosis (Myelosclerosis)
01/2022
1Multiple Myeloma
01/2021
1Residual Neoplasm
01/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2020
1Dyspnea (Shortness of Breath)
12/2018
1Liver Diseases (Liver Disease)
06/2018
1Lymphoma (Lymphomas)
01/2018
1Hyperplasia
12/2010
1Carcinoma (Carcinomatosis)
04/2010
1Hemangioma (Angioma)
11/2009
1Rectal Neoplasms (Rectal Cancer)
10/2009
1Wounds and Injuries (Trauma)
08/2009
1Renal Insufficiency (Renal Failure)
04/2008
1Renal Artery Obstruction (Renal Artery Stenosis)
04/2008
1Hypertension (High Blood Pressure)
04/2008
1Diabetes Mellitus
03/2008
1Chronic Renal Insufficiency
03/2008
1Tachycardia (Tachyarrhythmias)
12/2007
1Invasive Pulmonary Aspergillosis
03/2007

Drug/Important Bio-Agent (IBA)

11gadolinium ethoxybenzyl DTPAFDA Link
08/2020 - 05/2006
7gadobenic acid (gadobenate dimeglumine)FDA Link
10/2019 - 05/2003
5Contrast MediaIBA
06/2018 - 05/2003
3ferumoxides (Feridex)FDA Link
11/2009 - 05/2003
2Pentetic Acid (DTPA)FDA LinkGeneric
07/2011 - 07/2008
2IodineIBA
03/2008 - 12/2007
2iodixanol (Visipaque)FDA Link
03/2008 - 12/2007
1artemisinin (artemisinine)IBA
11/2019
1Antineoplastic Agents (Antineoplastics)IBA
11/2019
1Biomarkers (Surrogate Marker)IBA
06/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2018
1CateninsIBA
01/2013
1GadoliniumIBA
07/2008
1CreatinineIBA
03/2008
1SolutionsIBA
03/2008
1Saline SolutionIBA
03/2008
1Sodium Glutamate (Accent)IBA
03/2007
1ferric oxide (iron oxide)IBA
05/2003
1Tumor Biomarkers (Tumor Markers)IBA
03/2003

Therapy/Procedure

3Therapeutics
05/2020 - 07/2002
3Drug Therapy (Chemotherapy)
05/2020 - 08/2014
2Stem Cell Transplantation
01/2022 - 01/2021
2Transplantation
01/2022 - 07/2002
2Aftercare (After-Treatment)
01/2021 - 04/2018
1Cesarean Section (Caesarean Section)
03/2022
1Pancreatectomy
04/2010
1Stents
08/2009
1Lymph Node Excision (Lymph Node Dissection)
07/2008
1Contraindications
07/2008
1Radiofrequency Ablation
05/2006
1Electrodes (Electrode)
05/2006